Use of nonaspirin NSAIDs and risk of lung cancer

International Journal of Cancer

Volumn 117, Issue 5, 2005, Pages 873-876

  Skriver, Mette Vinther ^a   Nørgaard, Mette ^a,b   Poulsen, Aslak Harbo ^c   Friis, Søren ^c   Harving, Henrik ^d   Fryzek, Jon ^b,e   McLaughlin, Joseph K ^b,e   Blot, William J ^b,e   Olsen, Jørgen H ^b,c   Sørensen, Henrik Toft ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; Non steroidal antiinflammatory drugs; Population based; Risk of lung cancer

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRESCRIPTION; PRIORITY JOURNAL;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES;

EID: 27744590967     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21260     Document Type: Article

References (28)

1. Baron JA. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 2003;37:1-24.
2. Thun MJ, Henley SJ, Patrano C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pathologic and clinical issues. J Natl Cancer Inst 2002;94:252-66.
3. Brown JR, DuBois RN. Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture. Chest 2004;125:134S-40S.
4. Sandler AB, Dubinett SM. COX-2 inhibition and lung cancer. Semin Oncol 2004;31:45-52.
5. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, Gilliland J, Doll R. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988;296:313-6.
6. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 1989;299:1247-50.
7. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-7.
8. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-46.
9. Sørensen HT, Friis S, Norgard B, Mellemkjær L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003;88:1687-92.
10. Holick CN, Michaud DS, Leitzmann MF, Willett WC, Giovannucci E. Aspirin use and lung cancer in men. Br J Cancer 2003;89:1705-8.
11. Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawke E. Aspirin use and mortality from cancer in a prospective study. Anticancer Res 2004;24:3177-84.
12. Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 1995;24:107-9.
13. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br Med J 2000;320:1642-6.
14. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL, Shore RE. Aspirin and lung cancer in women. Br J Cancer 2002;87:49-53.
15. Moysich KB, Menezes RJ, Ronsani A, Swede H, Reid ME, Cummings KM, Falkner KL, Loewen GM, Bepler G. Regular aspirin use and lung cancer risk. BMC Cancer 2002;2:31.
16. Harris RE, Beebe-Donk J, Schuller HM. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep 2002;9:693-5.
17. Muscat JE, Chen SQ, Richie JP Jr, Altorki NK, Citron M, Olson S, Neugut AI, Stellman SD. Risk of lung carcinoma among users of non-steroidal anti-inflammatory drugs. Cancer 2003;97:1732-6.
18. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
19. Mellemkjær L, Blot WJ, Sørensen HT, Thomassen JK, McLaughlin JK, Nielsen GL, Olsen JH. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002;53:173-81.
20. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997;44:535-9.
21. Breslow NE, Day NE. The design and analysis of cohort studies. Lyon: IARC, 1987.
22. Skuladottir H, Olsen JH, Hirsch FR. Incidence of lung cancer in Denmark: historical and actual status. Lung Cancer 2000;27:107-18.
23. Danish National Board of Health. Cancer incidence in Denmark 1999. Copenhagen: Danish National Board of Health, 2003.
24. Blot WJ, Fraumeni JF Jr. Lung and pleura. In: Scottenfeld D, Fraumeni J, eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996. p. 637-65.
25. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sørensen HT, Blot WJ. Confounding by indication in epidemiologic studies of commonly usee analgesics. Am J Therapeut 2002;9:199-205.
26. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
27. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 2000;51:511-23.
28. Smalley W, Ray W, Daughert J, Griffin M, Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Int Med 1999;159:161-6.